Skip to main content

Tonix Pharmaceuticals Holding Corp.

TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001430306

In the last 90 days, Tonix Pharmaceuticals Holding Corp. insiders filed 2 open-market purchases and 0 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $119.4M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Tonix Pharmaceuticals Holding Corp. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of TNXP: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders3241+9
Shares3.69M14.4M+10.7M (+290.7%)
Value$2.01M$5.81M+$3.80M (+188.6%)

New holders (11)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to TNXP in Q4 2023
InstitutionSharesValue% of portfolio
Alyeska Investment Group, L.P.2,702,702$1.09M0.01%
Marshall Wace, LLP2,400,000$960.0K0.00%
Rosalind Advisors, Inc.900,900$363.1K0.30%
Altium Capital Management LP540,025$217.6K0.15%
GTS Securities LLC14,083$5.67K0.00%
First Western Trust Bank10,320$4.16K0.00%
Crew Capital Management, Ltd.10,000$4.03K0.00%
Game Plan Financial Advisors, LLC37$150.00%
Able Wealth Management LLC31$120.00%
Parallel Advisors, LLC2$10.00%
Advisory Services Network, LLC1$00.00%

Sold out (2)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of TNXP in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Virtu Financial LLC66,989$37.0K
JPMorgan Chase & Co20,667$11.3K